-
1
-
-
77649216536
-
Membrane transporters in drug development
-
Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, Dahlin A, Evers R, Fischer V, Hillgren KM, Hoffmaster KA, Ishikawa T, Keppler D, Kim RB, Lee CA, Niemi M, Polli JW, Sugiyama Y, Swaan PW, Ware JA, Wright SH, Yee SW, Zamek-Gliszczynski MJ, Zhang L. 2010. Membrane transporters in drug development. Nat Rev Drug Discov 9(3):215-236.
-
(2010)
Nat Rev Drug Discov
, vol.9
, Issue.3
, pp. 215-236
-
-
Giacomini, K.M.1
Huang, S.M.2
Tweedie, D.J.3
Benet, L.Z.4
Brouwer, K.L.5
Chu, X.6
Dahlin, A.7
Evers, R.8
Fischer, V.9
Hillgren, K.M.10
Hoffmaster, K.A.11
Ishikawa, T.12
Keppler, D.13
Kim, R.B.14
Lee, C.A.15
Niemi, M.16
Polli, J.W.17
Sugiyama, Y.18
Swaan, P.W.19
Ware, J.A.20
Wright, S.H.21
Yee, S.W.22
Zamek-Gliszczynski, M.J.23
Zhang, L.24
more..
-
2
-
-
71949102481
-
Interplay of drug metabolism and transport: A real phenomenon or an artifact of the site of measurement
-
Endres CJ, Endres MG, Unadkat JD. 2009. Interplay of drug metabolism and transport: A real phenomenon or an artifact of the site of measurement? Mol Pharm 6(6):1756-1765.
-
(2009)
Mol Pharm
, vol.6
, Issue.6
, pp. 1756-1765
-
-
Endres, C.J.1
Endres, M.G.2
Unadkat, J.D.3
-
3
-
-
33644835354
-
The role of transporters in drug interactions
-
Endres CJ, Hsiao P, Chung FS, Unadkat JD. 2006. The role of transporters in drug interactions. Eur J Pharm Sci 27(5):501-517.
-
(2006)
Eur J Pharm Sci
, vol.27
, Issue.5
, pp. 501-517
-
-
Endres, C.J.1
Hsiao, P.2
Chung, F.S.3
Unadkat, J.D.4
-
4
-
-
66149097607
-
Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3
-
Govindarajan R, Leung GP, Zhou M, Tse CM, Wang J, Unadkat JD. 2009. Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3. Am J Physiol Gastrointest Liver Physiol 296(4):G910-G922.
-
(2009)
Am J Physiol Gastrointest Liver Physiol
, vol.296
, Issue.4
-
-
Govindarajan, R.1
Leung, G.P.2
Zhou, M.3
Tse, C.M.4
Wang, J.5
Unadkat, J.D.6
-
5
-
-
1042301403
-
Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs
-
Lai Y, Tse CM, Unadkat JD. 2004. Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs. J Biol Chem 279(6):4490-4497.
-
(2004)
J Biol Chem
, vol.279
, Issue.6
, pp. 4490-4497
-
-
Lai, Y.1
Tse, C.M.2
Unadkat, J.D.3
-
6
-
-
84859899906
-
Interindividual variability in hepatic expression of the multidrug resistance-associated protein 2 (MRP2/ABCC2): Quantification by liquid chromatography/tandem mass spectrometry
-
Deo AK, Prasad B, Balogh L, Lai Y, Unadkat JD. 2012. Interindividual variability in hepatic expression of the multidrug resistance-associated protein 2 (MRP2/ABCC2): Quantification by liquid chromatography/tandem mass spectrometry. Drug Metab Dispos 40(5):852-855.
-
(2012)
Drug Metab Dispos
, vol.40
, Issue.5
, pp. 852-855
-
-
Deo, A.K.1
Prasad, B.2
Balogh, L.3
Lai, Y.4
Unadkat, J.D.5
-
7
-
-
64649105304
-
LC-MS/MS mediated absolute quantification and comparison of bile salt export pump and breast cancer resistance protein in livers and hepatocytes across species
-
Li N, Palandra J, Nemirovskiy OV, Lai Y. 2009. LC-MS/MS mediated absolute quantification and comparison of bile salt export pump and breast cancer resistance protein in livers and hepatocytes across species. Anal Chem 81(6):2251-2259.
-
(2009)
Anal Chem
, vol.81
, Issue.6
, pp. 2251-2259
-
-
Li, N.1
Palandra, J.2
Nemirovskiy, O.V.3
Lai, Y.4
-
8
-
-
84455194082
-
Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: Comparison with mRNA levels and activities
-
Ohtsuki S, Schaefer O, Kawakami H, Inoue T, Liehner S, Saito A, Ishiguro N, Kishimoto W, Ludwig-Schwellinger E, Ebner T, Terasaki T. 2012. Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: Comparison with mRNA levels and activities. Drug Metab Dispos 40(1):83-92.
-
(2012)
Drug Metab Dispos
, vol.40
, Issue.1
, pp. 83-92
-
-
Ohtsuki, S.1
Schaefer, O.2
Kawakami, H.3
Inoue, T.4
Liehner, S.5
Saito, A.6
Ishiguro, N.7
Kishimoto, W.8
Ludwig-Schwellinger, E.9
Ebner, T.10
Terasaki, T.11
-
9
-
-
43049114146
-
Quantitative atlas of membrane transporter proteins: Development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria
-
Kamiie J, Ohtsuki S, Iwase R, Ohmine K, Katsukura Y, Yanai K, Sekine Y, Uchida Y, Ito S, Terasaki T. 2008. Quantitative atlas of membrane transporter proteins: Development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria. Pharm Res 25(6):1469-1483.
-
(2008)
Pharm Res
, vol.25
, Issue.6
, pp. 1469-1483
-
-
Kamiie, J.1
Ohtsuki, S.2
Iwase, R.3
Ohmine, K.4
Katsukura, Y.5
Yanai, K.6
Sekine, Y.7
Uchida, Y.8
Ito, S.9
Terasaki, T.10
-
10
-
-
84455163180
-
Absolute quantification and differential expression of drug transporters, cytochrome P450 enzymes, and UDP-glucuronosyltransferases in cultured primary human hepatocytes
-
Schaefer O, Ohtsuki S, Kawakami H, Inoue T, Liehner S, Saito A, Sakamoto A, Ishiguro N, Matsumaru T, Terasaki T, Ebner T. 2012. Absolute quantification and differential expression of drug transporters, cytochrome P450 enzymes, and UDP-glucuronosyltransferases in cultured primary human hepatocytes. Drug Metab Dispos 40(1):93-103.
-
(2012)
Drug Metab Dispos
, vol.40
, Issue.1
, pp. 93-103
-
-
Schaefer, O.1
Ohtsuki, S.2
Kawakami, H.3
Inoue, T.4
Liehner, S.5
Saito, A.6
Sakamoto, A.7
Ishiguro, N.8
Matsumaru, T.9
Terasaki, T.10
Ebner, T.11
-
11
-
-
77958025244
-
Structure and function of the human breast cancer resistance protein (BCRP/ABCG2)
-
Ni Z, Bikadi Z, Rosenberg MF, Mao Q. 2010. Structure and function of the human breast cancer resistance protein (BCRP/ABCG2). Curr Drug Metab 11(7):603-617.
-
(2010)
Curr Drug Metab
, vol.11
, Issue.7
, pp. 603-617
-
-
Ni, Z.1
Bikadi, Z.2
Rosenberg, M.F.3
Mao, Q.4
-
12
-
-
0035502455
-
Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients
-
Asberg A, Hartmann A, Fjeldsa E, Bergan S, Holdaas H. 2001. Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients. Am J Transplant 1(4):382-386.
-
(2001)
Am J Transplant
, vol.1
, Issue.4
, pp. 382-386
-
-
Asberg, A.1
Hartmann, A.2
Fjeldsa, E.3
Bergan, S.4
Holdaas, H.5
-
13
-
-
1642523136
-
Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression
-
Hedman M, Neuvonen PJ, Neuvonen M, Holmberg C, Antikainen M. 2004. Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression. Clin Pharmacol Ther 75(1):101-109.
-
(2004)
Clin Pharmacol Ther
, vol.75
, Issue.1
, pp. 101-109
-
-
Hedman, M.1
Neuvonen, P.J.2
Neuvonen, M.3
Holmberg, C.4
Antikainen, M.5
-
14
-
-
0036792736
-
Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A
-
Park JW, Siekmeier R, Merz M, Krell B, Harder S, Marz W, Seidel D, Schuler S, Gross W. 2002. Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A. Int J Clin Pharmacol Ther 40(10):439-450.
-
(2002)
Int J Clin Pharmacol Ther
, vol.40
, Issue.10
, pp. 439-450
-
-
Park, J.W.1
Siekmeier, R.2
Merz, M.3
Krell, B.4
Harder, S.5
Marz, W.6
Seidel, D.7
Schuler, S.8
Gross, W.9
-
15
-
-
3542992126
-
Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine
-
Simonson SG, Raza A, Martin PD, Mitchell PD, Jarcho JA, Brown CD, Windass AS, Schneck DW. 2004. Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine. Clin Pharmacol Ther 76(2):167-177.
-
(2004)
Clin Pharmacol Ther
, vol.76
, Issue.2
, pp. 167-177
-
-
Simonson, S.G.1
Raza, A.2
Martin, P.D.3
Mitchell, P.D.4
Jarcho, J.A.5
Brown, C.D.6
Windass, A.S.7
Schneck, D.W.8
-
16
-
-
77951499767
-
ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin
-
Tomlinson B, Hu M, Lee VW, Lui SS, Chu TT, Poon EW, Ko GT, Baum L, Tam LS, Li EK. 2010. ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin. Clin Pharmacol Ther 87(5):558-562.
-
(2010)
Clin Pharmacol Ther
, vol.87
, Issue.5
, pp. 558-562
-
-
Tomlinson, B.1
Hu, M.2
Lee, V.W.3
Lui, S.S.4
Chu, T.T.5
Poon, E.W.6
Ko, G.T.7
Baum, L.8
Tam, L.S.9
Li, E.K.10
-
17
-
-
0031445547
-
Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism
-
Paine MF, Khalighi M, Fisher JM, Shen DD, Kunze KL, Marsh CL, Perkins JD, Thummel KE. 1997. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J Pharmacol Exp Ther 283(3):1552-1562.
-
(1997)
J Pharmacol Exp Ther
, vol.283
, Issue.3
, pp. 1552-1562
-
-
Paine, M.F.1
Khalighi, M.2
Fisher, J.M.3
Shen, D.D.4
Kunze, K.L.5
Marsh, C.L.6
Perkins, J.D.7
Thummel, K.E.8
-
18
-
-
77952313395
-
Human liver expression of CYP2C8: Gender, age, and genotype effects
-
Naraharisetti SB, Lin YS, Rieder MJ, Marciante KD, Psaty BM, Thummel KE, Totah RA. 2010. Human liver expression of CYP2C8: Gender, age, and genotype effects. Drug Metab Dispos 38(6):889-893.
-
(2010)
Drug Metab Dispos
, vol.38
, Issue.6
, pp. 889-893
-
-
Naraharisetti, S.B.1
Lin, Y.S.2
Rieder, M.J.3
Marciante, K.D.4
Psaty, B.M.5
Thummel, K.E.6
Totah, R.A.7
-
19
-
-
17844372454
-
Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver
-
Merino G, van Herwaarden AE, Wagenaar E, Jonker JW, Schinkel AH. 2005. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver. Mol Pharmacol 67(5):1765-1771.
-
(2005)
Mol Pharmacol
, vol.67
, Issue.5
, pp. 1765-1771
-
-
Merino, G.1
van Herwaarden, A.E.2
Wagenaar, E.3
Jonker, J.W.4
Schinkel, A.H.5
-
20
-
-
0141920354
-
Comparing protein abundance and mRNA expression levels on a genomic scale
-
Greenbaum D, Colangelo C, Williams K, Gerstein M. 2003. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 4(9):117.
-
(2003)
Genome Biol
, vol.4
, Issue.9
, pp. 117
-
-
Greenbaum, D.1
Colangelo, C.2
Williams, K.3
Gerstein, M.4
-
21
-
-
33845790070
-
Correlation of mRNA expression and protein abundance affected by multiple sequence features related to translational efficiency in Desulfovibrio vulgaris: A quantitative analysis
-
Nie L, Wu G, Zhang W. 2006. Correlation of mRNA expression and protein abundance affected by multiple sequence features related to translational efficiency in Desulfovibrio vulgaris: A quantitative analysis. Genetics 174(4):2229-2243.
-
(2006)
Genetics
, vol.174
, Issue.4
, pp. 2229-2243
-
-
Nie, L.1
Wu, G.2
Zhang, W.3
-
22
-
-
83955163683
-
Absolute immunoquantification of the expression of ABC transporters P-glycoprotein, breast cancer resistance protein and multidrug resistance-associated protein 2 in human liver and duodenum
-
Tucker TG, Milne AM, Fournel-Gigleux S, Fenner KS, Coughtrie MW. 2012. Absolute immunoquantification of the expression of ABC transporters P-glycoprotein, breast cancer resistance protein and multidrug resistance-associated protein 2 in human liver and duodenum. Biochem Pharmacol 83(2):279-285.
-
(2012)
Biochem Pharmacol
, vol.83
, Issue.2
, pp. 279-285
-
-
Tucker, T.G.1
Milne, A.M.2
Fournel-Gigleux, S.3
Fenner, K.S.4
Coughtrie, M.W.5
-
23
-
-
19944399722
-
Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta
-
Kobayashi D, Ieiri I, Hirota T, Takane H, Maegawa S, Kigawa J, Suzuki H, Nanba E, Oshimura M, Terakawa N, Otsubo K, Mine K, Sugiyama Y. 2005. Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta. Drug Metab Dispos 33(1):94-101.
-
(2005)
Drug Metab Dispos
, vol.33
, Issue.1
, pp. 94-101
-
-
Kobayashi, D.1
Ieiri, I.2
Hirota, T.3
Takane, H.4
Maegawa, S.5
Kigawa, J.6
Suzuki, H.7
Nanba, E.8
Oshimura, M.9
Terakawa, N.10
Otsubo, K.11
Mine, K.12
Sugiyama, Y.13
-
24
-
-
58549097067
-
Major SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations
-
Furukawa T, Wakabayashi K, Tamura A, Nakagawa H, Morishima Y, Osawa Y, Ishikawa T. 2009. Major SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations. Pharm Res 26(2):469-479.
-
(2009)
Pharm Res
, vol.26
, Issue.2
, pp. 469-479
-
-
Furukawa, T.1
Wakabayashi, K.2
Tamura, A.3
Nakagawa, H.4
Morishima, Y.5
Osawa, Y.6
Ishikawa, T.7
-
25
-
-
42449105678
-
Ubiquitin-mediated proteasomal degradation of non-synonymous SNP variants of human ABC transporter ABCG2
-
Nakagawa H, Tamura A, Wakabayashi K, Hoshijima K, Komada M, Yoshida T, Kometani S, Matsubara T, Mikuriya K, Ishikawa T. 2008. Ubiquitin-mediated proteasomal degradation of non-synonymous SNP variants of human ABC transporter ABCG2. Biochem J 411(3):623-631.
-
(2008)
Biochem J
, vol.411
, Issue.3
, pp. 623-631
-
-
Nakagawa, H.1
Tamura, A.2
Wakabayashi, K.3
Hoshijima, K.4
Komada, M.5
Yoshida, T.6
Kometani, S.7
Matsubara, T.8
Mikuriya, K.9
Ishikawa, T.10
-
26
-
-
33747884712
-
Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males
-
Zhang W, Yu BN, He YJ, Fan L, Li Q, Liu ZQ, Wang A, Liu YL, Tan ZR, Fen J, Huang YF, Zhou HH. 2006. Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males. Clin Chim Acta 373(1-2):99-103.
-
(2006)
Clin Chim Acta
, vol.373
, Issue.1-2
, pp. 99-103
-
-
Zhang, W.1
Yu, B.N.2
He, Y.J.3
Fan, L.4
Li, Q.5
Liu, Z.Q.6
Wang, A.7
Liu, Y.L.8
Tan, Z.R.9
Fen, J.10
Huang, Y.F.11
Zhou, H.H.12
-
27
-
-
70649110001
-
Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin
-
Keskitalo JE, Pasanen MK, Neuvonen PJ, Niemi M. 2009. Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin. Pharmacogenomics 10(10):1617-1624.
-
(2009)
Pharmacogenomics
, vol.10
, Issue.10
, pp. 1617-1624
-
-
Keskitalo, J.E.1
Pasanen, M.K.2
Neuvonen, P.J.3
Niemi, M.4
-
28
-
-
25144462079
-
Effect of ABCG2 genotype on the oral bioavailability of topotecan
-
Sparreboom A, Loos WJ, Burger H, Sissung TM, Verweij J, Figg WD, Nooter K, Gelderblom H. 2005. Effect of ABCG2 genotype on the oral bioavailability of topotecan. Cancer Biol Ther 4(6):650-658.
-
(2005)
Cancer Biol Ther
, vol.4
, Issue.6
, pp. 650-658
-
-
Sparreboom, A.1
Loos, W.J.2
Burger, H.3
Sissung, T.M.4
Verweij, J.5
Figg, W.D.6
Nooter, K.7
Gelderblom, H.8
-
29
-
-
45549106377
-
Pharmacogenetic characterization of sulfasalazine disposition based on NAT2 and ABCG2 (BCRP) gene polymorphisms in humans
-
Yamasaki Y, Ieiri I, Kusuhara H, Sasaki T, Kimura M, Tabuchi H, Ando Y, Irie S, Ware J, Nakai Y, Higuchi S, Sugiyama Y. 2008. Pharmacogenetic characterization of sulfasalazine disposition based on NAT2 and ABCG2 (BCRP) gene polymorphisms in humans. Clin Pharmacol Ther 84(1):95-103.
-
(2008)
Clin Pharmacol Ther
, vol.84
, Issue.1
, pp. 95-103
-
-
Yamasaki, Y.1
Ieiri, I.2
Kusuhara, H.3
Sasaki, T.4
Kimura, M.5
Tabuchi, H.6
Ando, Y.7
Irie, S.8
Ware, J.9
Nakai, Y.10
Higuchi, S.11
Sugiyama, Y.12
-
30
-
-
57049083981
-
Association of three genetic loci with uric acid concentration and risk of gout: A genome-wide association study
-
Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, Boerwinkle E, Levy D, Hofman A, Astor BC, Benjamin EJ, van Duijn CM, Witteman JC, Coresh J, Fox CS. 2008. Association of three genetic loci with uric acid concentration and risk of gout: A genome-wide association study. Lancet 372(9654):1953-1961.
-
(2008)
Lancet
, vol.372
, Issue.9654
, pp. 1953-1961
-
-
Dehghan, A.1
Kottgen, A.2
Yang, Q.3
Hwang, S.J.4
Kao, W.L.5
Rivadeneira, F.6
Boerwinkle, E.7
Levy, D.8
Hofman, A.9
Astor, B.C.10
Benjamin, E.J.11
van Duijn, C.M.12
Witteman, J.C.13
Coresh, J.14
Fox, C.S.15
-
31
-
-
79952797990
-
Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors
-
Yang Q, Kottgen A, Dehghan A, Smith AV, Glazer NL, Chen MH, Chasman DI, Aspelund T, Eiriksdottir G, Harris TB, Launer L, Nalls M, Hernandez D, Arking DE, Boerwinkle E, Grove ML, Li M, Linda Kao WH, Chonchol M, Haritunians T, Li G, Lumley T, Psaty BM, Shlipak M, Hwang SJ, Larson MG, O'Donnell CJ, Upadhyay A, van Duijn CM, Hofman A, Rivadeneira F, Stricker B, Uitterlinden AG, Pare G, Parker AN, Ridker PM, Siscovick DS, Gudnason V, Witteman JC, Fox CS, Coresh J. 2010. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet 3(6):523-530.
-
(2010)
Circ Cardiovasc Genet
, vol.3
, Issue.6
, pp. 523-530
-
-
Yang, Q.1
Kottgen, A.2
Dehghan, A.3
Smith, A.V.4
Glazer, N.L.5
Chen, M.H.6
Chasman, D.I.7
Aspelund, T.8
Eiriksdottir, G.9
Harris, T.B.10
Launer, L.11
Nalls, M.12
Hernandez, D.13
Arking, D.E.14
Boerwinkle, E.15
Grove, M.L.16
Li, M.17
Linda, K.W.18
Chonchol, M.19
Haritunians, T.20
Li, G.21
Lumley, T.22
Psaty, B.M.23
Shlipak, M.24
Hwang, S.J.25
Larson, M.G.26
O'Donnell, C.J.27
Upadhyay, A.28
van Duijn, C.M.29
Hofman, A.30
Rivadeneira, F.31
Stricker, B.32
Uitterlinden, A.G.33
Pare, G.34
Parker, A.N.35
Ridker, P.M.36
Siscovick, D.S.37
Gudnason, V.38
Witteman, J.C.39
Fox, C.S.40
Coresh, J.41
more..
-
32
-
-
77953967726
-
ABCG2 421C>A polymorphism and high exposure of sunitinib in a patient with renal cell carcinoma
-
Mizuno T, Terada T, Kamba T, Fukudo M, Katsura T, Nakamura E, Ogawa O, Inui K. 2010. ABCG2 421C>A polymorphism and high exposure of sunitinib in a patient with renal cell carcinoma. Ann Oncol 21(6):1382-1383.
-
(2010)
Ann Oncol
, vol.21
, Issue.6
, pp. 1382-1383
-
-
Mizuno, T.1
Terada, T.2
Kamba, T.3
Fukudo, M.4
Katsura, T.5
Nakamura, E.6
Ogawa, O.7
Inui, K.8
-
33
-
-
68749095215
-
Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinoma
-
Thomas F, Rochaix P, White-Koning M, Hennebelle I, Sarini J, Benlyazid A, Malard L, Lefebvre JL, Chatelut E, Delord JP. 2009. Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinoma. Eur J Cancer 45(13):2316-2323.
-
(2009)
Eur J Cancer
, vol.45
, Issue.13
, pp. 2316-2323
-
-
Thomas, F.1
Rochaix, P.2
White-Koning, M.3
Hennebelle, I.4
Sarini, J.5
Benlyazid, A.6
Malard, L.7
Lefebvre, J.L.8
Chatelut, E.9
Delord, J.P.10
-
34
-
-
0036089341
-
Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism
-
Lin YS, Dowling AL, Quigley SD, Farin FM, Zhang J, Lamba J, Schuetz EG, Thummel KE. 2002. Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism. Mol Pharmacol 62(1):162-172.
-
(2002)
Mol Pharmacol
, vol.62
, Issue.1
, pp. 162-172
-
-
Lin, Y.S.1
Dowling, A.L.2
Quigley, S.D.3
Farin, F.M.4
Zhang, J.5
Lamba, J.6
Schuetz, E.G.7
Thummel, K.E.8
-
35
-
-
80051544848
-
Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5
-
Kaspera R, Naraharisetti SB, Evangelista EA, Marciante KD, Psaty BM, Totah RA. 2011. Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5. Biochem Pharmacol 82(6):681-691.
-
(2011)
Biochem Pharmacol
, vol.82
, Issue.6
, pp. 681-691
-
-
Kaspera, R.1
Naraharisetti, S.B.2
Evangelista, E.A.3
Marciante, K.D.4
Psaty, B.M.5
Totah, R.A.6
|